Skip to content

Depression: all studies

Page 620 of 1,034: studies 6,191 to 6,200 of 10,336, newest first. Back to the depression overview

Research

The use of mindfulness-based stress reduction (MBSR) for breast cancer patients-meta-analysis.

BMC Psychology November 1, 2024 Xue Dong, Yan Liu, Kui Fang et al. 33 citations

Mindfulness-based stress reduction (MBSR) intervention has been widely used to reduce the burden of symptoms in cancer patients, and its effectiveness has been proven. However, the effectiveness of MBSR on depression, anxiety, fatigue, quality of life (QOL), posttraumatic growth (PTG), fear of cancer recurrence (FCR), pain, and sleep in breast cancer patients has not yet been determined. This...

DOI: 10.1186/s40359-024-02092-y (opens in new tab) Full text (opens in new tab) Breast cancer Meta-analysis Mindfulness-based stress reduction Pain +3

Feasibility and effects of mindfulness-based stress reduction (MBSR) for improving resilience, posttraumatic stress disorder symptoms and posttraumatic growth among military medical college students.

Acta Psychologica November 1, 2024 Xiaofan Yan, Xiaojie Wang, Yanli Chen et al. 11 citations

Increased stress among medical students in military college has been a challenge in the field of education. One approach to addressing stress reduction is mindfulness training. MBSR has been verified to improve the health status of different individuals. The aim of this study was to examine whether MBSR improves the psychological resilience, posttraumatic stress and posttraumatic growth of...

Residential Meditation Retreats: A Promise of Sustainable Well-Being?

Cureus November 1, 2024 Selvaraj Giridharan 2 citations

Meditation retreats are structured programs that immerse participants in focused meditation, mindfulness, and self-reflection over extended periods. Unlike conventional vacations, which prioritize relaxation, meditation retreats combine intensive practice with intentional rest, cultivating emotional regulation, mindfulness, and personal growth. These retreats have grown in popularity for their...

Improved implicit self-esteem is associated with extended antidepressant effects following a novel synergistic intervention.

Molecular Psychiatry November 1, 2024 H Nur Eken, Crystal Spotts, Benjamin Panny et al. 1 citation

In a previously published randomized controlled trial, automated self-association training (ASAT), a novel digital intervention, was found to extend the rapid antidepressant effect of a single infusion of ketamine for at least 30 days. In this secondary analysis, we aimed to understand the potential role of implicit self-esteem in the combined antidepressant effect of ketamine and ASAT...

Distinct synaptic mechanisms drive the behavioral response to acute stress and rapid correction by ketamine.

Neuropsychopharmacology November 1, 2024 Ji-Woon Kim, Benjamin Kleinfelter, Ege T Kavalali et al. 3 citations

Prevailing hypotheses on the mechanisms of antidepressant action posit that antidepressants directly counteract deficiencies in major neurotransmitter signaling systems that underlie depression. The rapidly acting antidepressant ketamine has been postulated to correct excess glutamatergic signaling via glutamatergic antagonism leading to the rescue of neuronal structural deficits and reversal...

DOI: 10.1038/s41386-024-01908-0 (opens in new tab) Full text (opens in new tab) Depression treatment Ketamine research Brain chemistry Psychopharmacology

Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions.

Neuropharmacology November 1, 2024 Thi Mai Loan Nguyen, Jean-Philippe Guilloux, Céline Defaix et al. 3 citations

(R,S)-ketamine (ketamine) has rapid and sustained antidepressant (AD) efficacy at sub-anesthetic doses in depressed patients. A metabolite of ketamine, including (2R,6R)-hydroxynorketamine ((6)-HNKs) has been reported to exert antidepressant actions in rodent model of anxiety/depression. To further understand the specific role of ketamine's metabolism in the AD actions of the drug, we evaluated...

DOI: 10.1016/j.neuropharm.2024.110065 (opens in new tab) Full text (opens in new tab) R,s-ketamine Cytochrome p450 inhibitor Fluconazole Gaba +10

A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy Volunteers.

Clinical Pharmacology & Therapeutics November 1, 2024 Shruti M Raja, Jeffrey T Guptill, Michelle Mack et al. 34 citations

(R,S)-Ketamine (ketamine) is a dissociative anesthetic that also possesses analgesic and antidepressant activity. Undesirable dissociative side effects and misuse potential limit expanded use of ketamine in several mental health disorders despite promising clinical activity and intensifying medical need. (2R,6R)-Hydroxynorketamine (RR-HNK) is a metabolite of ketamine that lacks anesthetic and...

DOI: 10.1002/cpt.3391 (opens in new tab) Full text (opens in new tab) Clinical-trials Antidepressants Ketamine-research Psychopharmacology +1

Ketamine - An Imperfect Wonder Drug?

Biochemical Pharmacology November 1, 2024 Tanner Magruder, Marielle Isenhart, Maximillian V Striepe et al. 8 citations

Ketamine is a potent sedative and dissociative anesthetic agent that has been used clinically for over 50 years since it was first developed in the 1960 s as an alternative to phencyclidine (PCP). When compared to PCP, ketamine exhibited a much lower incidence of severe side effects, including hallucinations, leading to its increased popularity in clinical practice. Ketamine was initially used...

KETAMINE: Neural- and network-level changes.

Neuroscience November 1, 2024 Vishal Bharmauria, Hamidreza Ramezanpour, Afef Ouelhazi et al.

Ketamine is a widely used clinical drug that has several functional and clinical applications, including its use as an anaesthetic, analgesic, anti-depressive, anti-suicidal agent, among others. Among its diverse behavioral effects, it influences short-term memory and induces psychedelic effects. At the neural level across different brain areas, it modulates neural firing rates, neural tuning,...

How Should We Expand Access to Psychedelics While Maintaining an Environment of Peace and Safety?

AMA journal of ethics November 1, 2024 Zachary J Verne, Jeffrey S Zabinski 1 citation

Psychedelics have long been used by individuals seeking peace and a sense of wellness. This article examines widespread adoption of ketamine as a proxy for psychedelics. For ketamine, there is a need to protect vulnerable persons from exploitation that should be balanced against risks of hypermedicalization. This article suggests strategies for striking such a balance, including by carefully...

DOI: 10.1001/amajethics.2024.868 (opens in new tab) Full text (opens in new tab) Psychedelic therapy Ketamine clinics Medical safety protocols Mental health treatment +1